Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Oct 29;93(22):12072–12075. doi: 10.1073/pnas.93.22.12072

Transplantation tolerance: fooling mother nature.

M Suthanthiran 1
PMCID: PMC37943  PMID: 8901533

Full text

PDF
12072

Images in this article

12073Fig. 1
on p.12073
12074Fig. 2
on p.12074
12074Fig. 3
on p.12074

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison J. P., Krummel M. F. The Yin and Yang of T cell costimulation. Science. 1995 Nov 10;270(5238):932–933. doi: 10.1126/science.270.5238.932. [DOI] [PubMed] [Google Scholar]
  2. AyanlarBatuman O., Ferrero A. P., Diaz A., Jimenez S. A. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest. 1991 Nov;88(5):1574–1580. doi: 10.1172/JCI115469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Azuma H., Binder J., Heemann U., Schmid C., Tullius S. G., Tilney N. L. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation. 1995 Feb 27;59(4):460–466. [PubMed] [Google Scholar]
  4. Azuma H., Chandraker A., Nadeau K., Hancock W. W., Carpenter C. B., Tilney N. L., Sayegh M. H. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12439–12444. doi: 10.1073/pnas.93.22.12439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ball S. T., Dallman M. J. Transplantation immunology. Curr Opin Nephrol Hypertens. 1995 Nov;4(6):465–471. doi: 10.1097/00041552-199511000-00001. [DOI] [PubMed] [Google Scholar]
  6. Becker J. C., Bröcker E. B. Prevention of anergy induction in cloned T cells by interleukin 12. Exp Dermatol. 1994 Dec;3(6):283–289. doi: 10.1111/j.1600-0625.1994.tb00290.x. [DOI] [PubMed] [Google Scholar]
  7. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R. C. A role for CD95 ligand in preventing graft rejection. Nature. 1995 Oct 19;377(6550):630–632. doi: 10.1038/377630a0. [DOI] [PubMed] [Google Scholar]
  8. Bia M. J. Nonimmunologic causes of late renal graft loss. Kidney Int. 1995 May;47(5):1470–1480. doi: 10.1038/ki.1995.206. [DOI] [PubMed] [Google Scholar]
  9. Bluestone J. A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 1995 Jun;2(6):555–559. doi: 10.1016/1074-7613(95)90000-4. [DOI] [PubMed] [Google Scholar]
  10. Border W. A., Noble N. A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 Nov 10;331(19):1286–1292. doi: 10.1056/NEJM199411103311907. [DOI] [PubMed] [Google Scholar]
  11. Brenner B. M., Cohen R. A., Milford E. L. In renal transplantation, one size may not fit all. J Am Soc Nephrol. 1992 Aug;3(2):162–169. doi: 10.1681/ASN.V32162. [DOI] [PubMed] [Google Scholar]
  12. Carpenter C. B. Long-term failure of renal transplants: adding insult to injury. Kidney Int Suppl. 1995 Aug;50:S40–S44. [PubMed] [Google Scholar]
  13. Charlton B., Auchincloss H., Jr, Fathman C. G. Mechanisms of transplantation tolerance. Annu Rev Immunol. 1994;12:707–734. doi: 10.1146/annurev.iy.12.040194.003423. [DOI] [PubMed] [Google Scholar]
  14. Germain R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994 Jan 28;76(2):287–299. doi: 10.1016/0092-8674(94)90336-0. [DOI] [PubMed] [Google Scholar]
  15. Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995 Nov 17;270(5239):1189–1192. doi: 10.1126/science.270.5239.1189. [DOI] [PubMed] [Google Scholar]
  16. Groux H., Bigler M., de Vries J. E., Roncarolo M. G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996 Jul 1;184(1):19–29. doi: 10.1084/jem.184.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jenkins M. K., Johnson J. G. Molecules involved in T-cell costimulation. Curr Opin Immunol. 1993 Jun;5(3):361–367. doi: 10.1016/0952-7915(93)90054-v. [DOI] [PubMed] [Google Scholar]
  18. Kapur S., Khanna A., Sharma V. K., Li B., Suthanthiran M. CD2 antigen targeting reduces intragraft expression of mRNA-encoding granzyme B and IL-10 and induces tolerance. Transplantation. 1996 Jul 27;62(2):249–255. doi: 10.1097/00007890-199607270-00017. [DOI] [PubMed] [Google Scholar]
  19. Krensky A. M., Weiss A., Crabtree G., Davis M. M., Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med. 1990 Feb 22;322(8):510–517. doi: 10.1056/NEJM199002223220805. [DOI] [PubMed] [Google Scholar]
  20. Kronenberg M. Self-tolerance and autoimmunity. Cell. 1991 May 17;65(4):537–542. doi: 10.1016/0092-8674(91)90086-e. [DOI] [PubMed] [Google Scholar]
  21. Kurihara H., Yoshizumi M., Sugiyama T., Takaku F., Yanagisawa M., Masaki T., Hamaoki M., Kato H., Yazaki Y. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 1989 Mar 31;159(3):1435–1440. doi: 10.1016/0006-291x(89)92270-5. [DOI] [PubMed] [Google Scholar]
  22. Larsen C. P., Alexander D. Z., Hollenbaugh D., Elwood E. T., Ritchie S. C., Aruffo A., Hendrix R., Pearson T. C. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation. 1996 Jan 15;61(1):4–9. doi: 10.1097/00007890-199601150-00002. [DOI] [PubMed] [Google Scholar]
  23. Lau H. T., Yu M., Fontana A., Stoeckert C. J., Jr Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science. 1996 Jul 5;273(5271):109–112. doi: 10.1126/science.273.5271.109. [DOI] [PubMed] [Google Scholar]
  24. Lenschow D. J., Zeng Y., Thistlethwaite J. R., Montag A., Brady W., Gibson M. G., Linsley P. S., Bluestone J. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 7;257(5071):789–792. doi: 10.1126/science.1323143. [DOI] [PubMed] [Google Scholar]
  25. Lenschow D. J., Zeng Y., Thistlethwaite J. R., Montag A., Brady W., Gibson M. G., Linsley P. S., Bluestone J. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 7;257(5071):789–792. doi: 10.1126/science.1323143. [DOI] [PubMed] [Google Scholar]
  26. Li B., Sehajpal P. K., Khanna A., Vlassara H., Cerami A., Stenzel K. H., Suthanthiran M. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med. 1991 Nov 1;174(5):1259–1262. doi: 10.1084/jem.174.5.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lin H., Bolling S. F., Linsley P. S., Wei R. Q., Gordon D., Thompson C. B., Turka L. A. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med. 1993 Nov 1;178(5):1801–1806. doi: 10.1084/jem.178.5.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Linsley P. S., Ledbetter J. A. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol. 1993;11:191–212. doi: 10.1146/annurev.iy.11.040193.001203. [DOI] [PubMed] [Google Scholar]
  29. Lipman M. L., Stevens A. C., Strom T. B. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol. 1994 May 15;152(10):5120–5127. [PubMed] [Google Scholar]
  30. McCartney-Francis N., Mizel D., Wong H., Wahl L., Wahl S. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors. 1990;4(1):27–35. doi: 10.3109/08977199009011007. [DOI] [PubMed] [Google Scholar]
  31. Miller J. F., Flavell R. A. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr Opin Immunol. 1994 Dec;6(6):892–899. doi: 10.1016/0952-7915(94)90010-8. [DOI] [PubMed] [Google Scholar]
  32. Nickerson P., Steurer W., Steiger J., Zheng X., Steele A. W., Strom T. B. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol. 1994 Oct;6(5):757–764. doi: 10.1016/0952-7915(94)90081-7. [DOI] [PubMed] [Google Scholar]
  33. Noel P. J., Boise L. H., Green J. M., Thompson C. B. CD28 costimulation prevents cell death during primary T cell activation. J Immunol. 1996 Jul 15;157(2):636–642. [PubMed] [Google Scholar]
  34. Nossal G. J. Molecular and cellular aspects of immunologic tolerance. Eur J Biochem. 1991 Dec 18;202(3):729–737. doi: 10.1111/j.1432-1033.1991.tb16427.x. [DOI] [PubMed] [Google Scholar]
  35. Paul L. C., Fellström B. Chronic vascular rejection of the heart and the kidney--have rational treatment options emerged? Transplantation. 1992 Jun;53(6):1169–1179. doi: 10.1097/00007890-199206000-00001. [DOI] [PubMed] [Google Scholar]
  36. Posselt A. M., Barker C. F., Tomaszewski J. E., Markmann J. F., Choti M. A., Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science. 1990 Sep 14;249(4974):1293–1295. doi: 10.1126/science.2119056. [DOI] [PubMed] [Google Scholar]
  37. Russell M. E., Hancock W. W., Akalin E., Wallace A. F., Glysing-Jensen T., Willett T. A., Sayegh M. H. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest. 1996 Feb 1;97(3):833–838. doi: 10.1172/JCI118483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sachs D. H. CCETS Basic Science Lecture. Transplantation tolerance. Ann Thorac Surg. 1993 Dec;56(6):1221–1227. doi: 10.1016/0003-4975(93)90657-4. [DOI] [PubMed] [Google Scholar]
  39. Sayegh M. H., Akalin E., Hancock W. W., Russell M. E., Carpenter C. B., Linsley P. S., Turka L. A. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med. 1995 May 1;181(5):1869–1874. doi: 10.1084/jem.181.5.1869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sayegh M. H., Turka L. A. T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol. 1995 Oct;6(4):1143–1150. doi: 10.1681/ASN.V641143. [DOI] [PubMed] [Google Scholar]
  41. Schwartz R. H. Models of T cell anergy: is there a common molecular mechanism? J Exp Med. 1996 Jul 1;184(1):1–8. doi: 10.1084/jem.184.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sharma V. K., Bologa R. M., Xu G. P., Li B., Mouradian J., Wang J., Serur D., Rao V., Suthanthiran M. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int. 1996 May;49(5):1297–1303. doi: 10.1038/ki.1996.185. [DOI] [PubMed] [Google Scholar]
  43. Sloan-Lancaster J., Allen P. M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol. 1996;14:1–27. doi: 10.1146/annurev.immunol.14.1.1. [DOI] [PubMed] [Google Scholar]
  44. Steiger J., Nickerson P. W., Steurer W., Moscovitch-Lopatin M., Strom T. B. IL-2 knockout recipient mice reject islet cell allografts. J Immunol. 1995 Jul 1;155(1):489–498. [PubMed] [Google Scholar]
  45. Streilein J. W. Unraveling immune privilege. Science. 1995 Nov 17;270(5239):1158–1159. doi: 10.1126/science.270.5239.1158. [DOI] [PubMed] [Google Scholar]
  46. Suthanthiran M. Signaling features of T cells: implications for the regulation of the anti-allograft response. Kidney Int Suppl. 1993 Oct;43:S3–11. [PubMed] [Google Scholar]
  47. Suthanthiran M., Strom T. B. Renal transplantation. N Engl J Med. 1994 Aug 11;331(6):365–376. doi: 10.1056/NEJM199408113310606. [DOI] [PubMed] [Google Scholar]
  48. Thompson C. B. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 1995 Jun 30;81(7):979–982. doi: 10.1016/s0092-8674(05)80001-7. [DOI] [PubMed] [Google Scholar]
  49. Tullius S. G., Tilney N. L. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation. 1995 Feb 15;59(3):313–318. [PubMed] [Google Scholar]
  50. Turka L. A., Linsley P. S., Lin H., Brady W., Leiden J. M., Wei R. Q., Gibson M. L., Zheng X. G., Myrdal S., Gordon D. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):11102–11105. doi: 10.1073/pnas.89.22.11102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Viola A., Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science. 1996 Jul 5;273(5271):104–106. doi: 10.1126/science.273.5271.104. [DOI] [PubMed] [Google Scholar]
  52. Waterhouse P., Penninger J. M., Timms E., Wakeham A., Shahinian A., Lee K. P., Thompson C. B., Griesser H., Mak T. W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995 Nov 10;270(5238):985–988. doi: 10.1126/science.270.5238.985. [DOI] [PubMed] [Google Scholar]
  53. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 1994 Jan 28;76(2):263–274. doi: 10.1016/0092-8674(94)90334-4. [DOI] [PubMed] [Google Scholar]
  54. Xu G. P., Sharma V. K., Li B., Bologa R., Li Y., Mouradian J., Wang J., Serur D., Rao V., Stenzel K. H. Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection. Kidney Int. 1995 Nov;48(5):1504–1507. doi: 10.1038/ki.1995.440. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES